ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMAG AMAG Pharmaceuticals Inc

13.75
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
AMAG Pharmaceuticals Inc NASDAQ:AMAG NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 13.75 13.04 13.90 0 01:00:00

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

01/03/2017 1:00pm

GlobeNewswire Inc.


AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more AMAG Pharmaceuticals Charts.

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences:

  • Cowen and Company Annual Health Care Conference Monday, March 6, 2017 at 2:40 p.m. ET  Location: Boston, MA
  • Raymond James Annual Institutional Investors Conference Wednesday, March 8, 2017 at 10:25 a.m. ET Location: Orlando, FL
  • Barclays Global Healthcare Conference Tuesday, March 14, 2017 at 2:35 p.m. ET Location: Miami, FL

To access the live webcasts, please visit the Investors section of the company’s website at www.amagpharma.com. A replay of each event will be archived on the site for 30 days.

About AMAGAMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of women's health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals Contact: 
Christi Waarich
Associate Director, Investor Relations
617-498-7638

1 Year AMAG Pharmaceuticals Chart

1 Year AMAG Pharmaceuticals Chart

1 Month AMAG Pharmaceuticals Chart

1 Month AMAG Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock